Title:
【発明の名称】選択的な抗B型肝炎ウイルス活性を有する鏡像体的に純粋なβ-D-ジオキソランヌクレオシド
Document Type and Number:
Japanese Patent JP3117217
Kind Code:
B2
Abstract:
A method and composition for the treatment of humans infected with HBV that includes the administration of an HBV treatment amount of a beta -dioxolanyl purine nucleoside of the formula: wherein R is OH, Cl, NH2, or H, or a pharmaceutically acceptable salt or derivative of the compound, optionally in a pharmaceutically acceptable carrier or diluent.
Inventors:
Skinny, raymond, pea
Application Number:
JP51131494A
Publication Date:
December 11, 2000
Filing Date:
October 28, 1993
Export Citation:
Assignee:
Emory University
International Classes:
A61K31/505; A61K31/506; A61K31/513; A61K31/52; A61K31/522; A61K31/53; A61K31/675; C07D473/18; A61K31/70; A61K31/7076; A61K31/708; A61K38/21; A61P31/12; A61P31/18; A61P31/20; A61P37/04; C07D327/04; C07D405/04; C07D411/04; C07D473/00; C07D473/02; C07D473/16; C07D473/30; C07D473/32; C07D473/34; C07D473/40; C07D497/08; (IPC1-7): A61K31/52; A61K31/522; A61P31/20
Domestic Patent References:
| JP1316375A |
Other References:
【文献】国際公開92/10497(WO,A1)
Attorney, Agent or Firm:
Hajime Tsukuni (2 outside)